Exact Mass: 385.0749430000001
Exact Mass Matches: 385.0749430000001
Found 33 metabolites which its exact mass value is equals to given mass value 385.0749430000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Hydroxylansoprazole
C16H14F3N3O3S (385.0707930000001)
Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Lansoprazole sulfone
C16H14F3N3O3S (385.0707930000001)
Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Alizarin complexone
Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
C20H19NO3S2 (385.0806304000001)
2,3-dimethylnaphtho[1,2-d]thiazolium tosylate
C20H19NO3S2 (385.0806304000001)
[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate
YS-49
C20H20BrNO2 (385.06773200000003)
YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].
2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid
C16H14F3N3O3S (385.0707930000001)
(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
C20H16ClNO5 (385.07169560000006)
tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate
(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate
C19H16ClN3O2S (385.06517060000004)
(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate
(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide
3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide
C19H16ClN3O2S (385.06517060000004)
N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide
C19H16ClN3O4 (385.08292860000006)
[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
aristolochicacid iva methyl ester
{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanamide
C14H20BrN5O3 (385.0749430000001)
(2e)-3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanimidic acid
C14H20BrN5O3 (385.0749430000001)